상세 보기
First-line (1L) trastuzumab deruxtecan (T-DXd) regimens in advanced HER2-positive (HER2+) gastric cancer (GC), gastroesophageal junction adenocarcinoma (GEJA), or esophageal adenocarcinoma (EA): Exploratory analysis of baseline HER2-related biomarkers in DESTINY-Gastric03 (DG-03) Part 2
- Janjigian, Yelena Y.;
- van Laarhoven, Hanneke;
- Rha, Sun Young;
- Kozlov, Vadim;
- Lee, Keun-Wook;
- ... Lee, Jeeyun;
- 외 16명
Citations
WEB OF SCIENCE
0- 제목
- First-line (1L) trastuzumab deruxtecan (T-DXd) regimens in advanced HER2-positive (HER2+) gastric cancer (GC), gastroesophageal junction adenocarcinoma (GEJA), or esophageal adenocarcinoma (EA): Exploratory analysis of baseline HER2-related biomarkers in DESTINY-Gastric03 (DG-03) Part 2
- 저자
- Janjigian, Yelena Y.; van Laarhoven, Hanneke; Rha, Sun Young; Kozlov, Vadim; Lee, Keun-Wook; Oh, Do-Youn; Gravina, Adriano; Ryu, Min-Hee; Rapatoni, Liane; Antunes, Luis; Pietrantonio, Filippo; Shoji, Hirokazu; Hofheinz, Ralf-Dieter; Chenard-Poirier, Maxime; Chen, Li-Tzong; Vasiliev, Aleksandr; Kutukova, Svetlana; Lambert, Arthur W.; Yu, Kun; Scott, Megan; Rabbie, Roy; Lee, Jeeyun
- 발행일
- 2026-04-17
- 유형
- Meeting Abstract
- 저널명
- Cancer Research
- 권
- 86
- 호
- 8
- 페이지
- LB010 ~ LB010